Author:
ÇABUŞ Ümit,KALELİ Babür,FENKCİ İ.veysel,KALELİ İlknur,DEMİR Süleyman
Reference33 articles.
1. 1 Ehrmann DA. Medical progress: polycystic ovary syndrome. N Engl J Med 2004: 352: 1223–1236
2. 2 Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG. 2006; 113(10): 1210-1217.
3. 3 Artimani T, Karimi J, Mehdizadeh M, et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2018; 34(2): 148-152.
4. 4 Mohammadi S, Kayedpoor P, Karimzadeh-Bardei L, Nabiuni M. The Effect of Curcumin on TNF-α, IL-6 and CRP Expression in a Model of Polycystic Ovary Syndrome as an Inflammation State. J Reprod Infertil. 2017; 18(4): 352-360.
5. 5 Amer SAK. Polycystic ovarian syndrome: diagnosis and management of related infertility. Obstet Gynaecol Reprod Med. 2009; 19(10): 263-270.